Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Rockwell Medical's price to sales ratio was 4.1× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.1× to 4.9×, with a median of 0.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | +3.6 |
| 2025 | Dec 31, 2025 | 0.4× | −0.2 |
| 2024 | Dec 31, 2024 | 0.7× | +0.0 |
| 2023 | Dec 29, 2023 | 0.7× | +0.5 |
| 2022 | Dec 30, 2022 | 0.2× | −0.5 |
| 2021 | Dec 31, 2021 | 0.6× | −0.9 |
| 2020 | Dec 31, 2020 | 1.5× | −1.0 |
| 2019 | Dec 31, 2019 | 2.5× | +0.6 |
| 2018 | Dec 31, 2018 | 1.9× | −3.5 |
| 2017 | Dec 29, 2017 | 5.4× | −0.9 |
| 2016 | Dec 30, 2016 | 6.2× | −3.0 |
| 2015 | Dec 31, 2015 | 9.2× | +1.4 |
| 2014 | Dec 31, 2014 | 7.9× | −0.3 |
| 2013 | Dec 31, 2013 | 8.1× | +5.0 |
| 2012 | Dec 31, 2012 | 3.1× | +0.0 |
| 2011 | Dec 30, 2011 | 3.0× | – |
See a number that looks wrong?